• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. TURON SHOULDER; HEAD, HUMERAL, NEUTRAL, 50-26

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. TURON SHOULDER; HEAD, HUMERAL, NEUTRAL, 50-26 Back to Search Results
Catalog Number 520-50-026
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 03/08/2017
Type of Reportable Event Serious Injury
Event or Problem Description
Revision surgery - the patient was infected and the surgeon made the spacer out of hemi parts months ago.The smaller stem and turon head encapsulated in cement.
 
Additional Manufacturer Narrative
The reason for this revision surgery was an infection.The previous surgery and the revision detailed in this investigation occurred over 3.8 months apart.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the possible infection or inhibited the patient's immune system.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to (b)(4) for examination.A review of the implant device history records (dhrs) show that the reported component used in the previous surgery met design and manufacturing requirements.There were no non-conforming material reports (ncmrs) associated with the product that may have contributed to an infection.Customer complaint history of the reported device (s) showed no present trends or on-going issues that are in need of review.The device was verified to have gone through an acceptable sterilization process and was within it's expiration date at the time of use during the previous surgery.There were no findings during this investigation that indicate that the reported device was the root cause or had a direct connection with the patient's infection.There are multiple factors that may contribute to an infection that are outside of the control of (b)(4).There are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TURON SHOULDER
Common Device Name
HEAD, HUMERAL, NEUTRAL, 50-26
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd.
austin TX 78758 5445
MDR Report Key6473590
Report Number1644408-2017-00206
Device Sequence Number16307316
Product Code KWS
UDI-Device Identifier00888912145220
UDI-Public(01)00888912145220
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K080402
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Device Explanted Year2017
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/28/2021
Device Catalogue Number520-50-026
Device Lot Number933C1046
Was Device Available for Evaluation? No
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 03/08/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/07/2017
Supplement Report FDA Received Date05/17/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
506-00-008,LOT 814C1248; 506-06-000,LOT 838C1072
Outcome Attributed to Adverse Event Required Intervention;
Patient Age53 YR
-
-